VERAPAMIL |
VERELAN |
CP-165331 |
NSC-272306NA |
CP-16533-1 |
TARKA |
ISOPTIN |
D-365 |
COVERA-HS |
IPROVERATRIL |
CALAN |
VERAPAMILO |
SECURON® |
CP-165331 / CP-16533-1 |
ANSYR® |
VERAPAMILUM |
VÉRAPAMIL |
pubchem.compound:2520 |
rxcui:11170 |
drugbank:00661 |
chemidplus:52-53-9 |
chembl:CHEMBL6966 |
Drug Class | anti-arrhythmia agents |
Year of Approval | 1981 |
Drug Categories | selective calcium channel blockers with direct cardiac effects |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antihypertensive agent |
Drug Categories | ace inhibitors and calcium channel blockers |
Drug Categories | adrenergic alpha-1 receptor antagonists |
Drug Categories | adrenergic alpha-antagonists |
Drug Categories | adrenergic antagonists |
Drug Categories | antiarrhythmic agents |
Drug Categories | antihypertensive agents |
Drug Categories | antihypertensive agents indicated for hypertension |
Drug Categories | cytochrome p-450 cyp2c18 substrates |
Drug Categories | cytochrome p-450 cyp2c8 inhibitors |
Drug Categories | cytochrome p-450 cyp2c8 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2c9 inhibitors (weak) |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2e1 substrates |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a5 inhibitors |
Drug Categories | cytochrome p-450 cyp3a5 inhibitors (moderate) |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | mate 1 inhibitors |
Drug Categories | mate 2 inhibitors |
Drug Categories | mate inhibitors |
Drug Categories | miscellaneous calcium-channel blocking agents |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | oct1 inhibitors |
Drug Categories | oct1 substrates |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | vasodilating agents |
Drug Categories | verapamil and analogues |
blocker (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Inhibition |
Direct Interaction? | False |
blocker (inhibitory) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | Inhibition |
blocker (inhibitory) |
Specific Action of the Ligand | None |
Endogenous Drug? | False |
n/a |
Drug family | Na-Ca chanel blocker |
Alteration | KCNJ5:L168R |
inhibitor (inhibitory) |
Trial Name | Verapamil,Calan, Covera-HS |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | Verapamil,Calan, Covera-HS |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | Verapamil,Calan, Covera-HS |
Novel drug target | Established target |
blocker (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | True |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Verapamil,Calan, Covera-HS |
blocker (inhibitory) |
Specific Action of the Ligand | None |
Endogenous Drug? | False |
blocker (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | None |
blocker (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | False |
inhibitor (inhibitory) |
Trial Name | Verapamil,Calan, Covera-HS |
Novel drug target | Established target |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction? | True |
Endogenous Drug? | False |
Specific Action of the Ligand | Antagonist |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
inhibitor (inhibitory) |
Details of the Assay for Interaction | Inhibition of testosterone 6β-hydroxylation. |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
52-53-9 | CAS Number |
Alti-verapamil - 120mg | Drug Brand |
Alti-verapamil - 80mg | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | ace inhibitors and calcium channel blockers |
Drug Indications | antihypertensive agent |
Drug Class | Small Molecule |
FDA Approval | approved |
Year of Approval | 1981 |
Drug Class | anti-arrhythmia agents |
CHEMBL6966 | ChEMBL Drug ID |
C928 | NCI drug code |
D0R0FE | TTD Drug ID |